User:Mr. Ibrahem/Tenecteplase

Tenecteplase (TNK), sold under the trade names TNKase among others, is a medication used to treat ST elevation myocardial infarction or pulmonary embolism with low blood pressure. It may also be used for stroke. It is given by injection into a vein.

Common side effects include bleeding such as nosebleeds, gastrointestinal bleeding, bruising, or blood in the urine. It should not be used by those with anaphylaxis to gentamicin. It is a tissue plasminogen activator (tPA) produced by recombinant DNA technology. It works by dissolving blood clots.

Tenecteplase was approved for medical use in the United States in 2000 and Europe in 2001. In the United Kingdom it costs the NHS about £600 per dose as of 2021. This amount in the United States costs about 6,500 USD.